A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder

Abroad (travel likely)
RecruitingPHASE3

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Conditions

Depressive Disorder, Major

Locations
  • Peachford Hospital-Atlanta Behavioral Research, Atlanta, Georgia, United States
  • University of Cincinnati, Cincinnati, Ohio, United States
  • Instituto Apice, Salvador, Brazil
  • Centro Integrado Facili, São Bernardo do Campo, Brazil
  • Taipei Veterans General Hospital, Taipei, Taiwan
  • Tri-Service General Hospital, Taipei, Taiwan